healthcanal.com
Candidate vaccine reduces malaria by approximately one-third in African infants - Healthcanal.com
Results from a large-scale clinical trial, published in the ‘New England Journal of Medicine’, have shown that a new candidate vaccine being developed by GlaxoSmithKline (GSK) can help protect African infants against malaria.